AI FOR SCIENCE · ON THE RECORD

Bristol Myers Squibb

Investor page →On the timeline →

Research on the record

2026-07-27Schrödinger opens early access to Bunsen, an AI agent that plans, runs and reads its physics-based molecular modelling, and Bristol Myers Squibb agrees to roll it out across its researchLevel 1 · Exists

Graded by how far the evidence went, not how good the result is. See the methodology.

Also on the timeline

2026-10-27Anthropic buys a one-person drug company and starts running drug programmes of its ownOrganizations
2026-10-23Pathos AI raises a $237M Series E led by Bristol Myers Squibb at about $3B, and takes its trial-steering AI from cancer into Alzheimer's with BMS and TempusCapital

Rounds it backed

2026-10-23Pathos AI · Series E · $237Mlead
2022-07-20BigHat Biosciences · Series B · $75Mparticipant
2022-06-07Owkin · Series B · part of $80M in aggregate with an upfront fee; equity share not broken outlead

Rounds on the funding record that name it as an investor, in the role each source gives. Its own rounds are not on the funding board, which covers AI4S startups; the timeline records them as events.

This page compiles what AI4S.fyi has recorded and links each item to its source. It is not a grade of the organization and not its complete history: a blank means the record has not caught up as often as it means nothing happened.